AJP - Endocrinology and Metabolism, Vol 256, Issue 5 E676-E681, Copyright © 1989 by American Physiological Society

ARTICLES

Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys

N. L. Bodkin, B. L. Metzger and B. C. Hansen
Department of Physiology, School of Nursing, University of Maryland, Baltimore 21201.

The purpose of this study was to identify the relationship between basal hepatic glucose production (HGP) and peripheral insulin sensitivity as assessed by the hyperinsulinemic euglycemic clamp prior to and during the development of non-insulin-dependent (type 2) diabetes mellitus in rhesus monkeys. Twenty-six male monkeys (Macaca mulatta), including normal animals and monkeys in various phases of the development of spontaneous obesity-associated type 2 diabetes were studied. Fasting plasma glucose (FPG) and insulin (FIRI), basal HGP using a [3H]glucose infusion, and peripheral insulin sensitivity (as determined by the euglycemic clamp technique) were examined. The earliest change that could be detected was a significant reduction in peripheral insulin sensitivity accompanied by increased FIRI. These changes preceded a significant deterioration of glucose tolerance. Basal HGP changed in parallel with FPG (r = 0.90, P less than 0.001), becoming significantly elevated only when FPG rose to levels diagnostic of diabetes (greater than 140 mg/dl). Thus basal HGP and fasting glucose levels showed no significant changes early in the development of type 2 diabetes. We conclude that the early serial decreases in insulin sensitivity and progressive increases in FIRI, with or without decreased glucose tolerance, are prognostic of the future development of diabetes in obese monkeys, a longitudinal process that is also likely to be observed in most if not all obese humans progressing to diabetes.

This article has been cited by other articles:

				H. K. Ortmeyer, Y. Adall, K. R. Marciani, A. Katsiaras, A. S. Ryan, N. L. Bodkin, and B. C. Hansen Skeletal muscle glycogen synthase subcellular localization: effects of insulin and PPAR-{alpha} agonist (K-111) administration in rhesus monkeys Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1509 - R1517. [Abstract] [Full Text] [PDF]

				R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]

				M. A. Lane, J. A. Mattison, G. S. Roth, L. J. Brant, and D. K. Ingram Effects of Long-Term Diet Restriction on Aging and Longevity in Primates Remain Uncertain J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): B405 - B407. [Full Text] [PDF]

				N. L. Bodkin, T. M. Alexander, H. K. Ortmeyer, E. Johnson, and B. C. Hansen Mortality and Morbidity in Laboratory-maintained Rhesus Monkeys and Effects of Long-term Dietary Restriction J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2003; 58(3): B212 - 219. [Abstract] [Full Text] [PDF]

				M. L. Standaert, H. K. Ortmeyer, M. P. Sajan, Y. Kanoh, G. Bandyopadhyay, B. C. Hansen, and R. V. Farese Skeletal Muscle Insulin Resistance in Obesity-Associated Type 2 Diabetes in Monkeys Is Linked to a Defect in Insulin Activation of Protein Kinase C-{zeta}/{lambda}/{iota} Diabetes, October 1, 2002; 51(10): 2936 - 2943. [Abstract] [Full Text] [PDF]

				D. A. Winegar, P. J. Brown, W. O. Wilkison, M. C. Lewis, R. J. Ott, W. Q. Tong, H. R. Brown, J. M. Lehmann, S. A. Kliewer, K. D. Plunket, et al. Effects of fenofibrate on lipid parameters in obese rhesus monkeys J. Lipid Res., October 1, 2001; 42(10): 1543 - 1551. [Abstract] [Full Text] [PDF]

				H. K. Ortmeyer and N. L. Bodkin Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulin-resistant monkeys Am J Physiol Gastrointest Liver Physiol, June 1, 1998; 274(6): G1005 - G1010. [Abstract] [Full Text] [PDF]

				K. Hotta, T. A. Gustafson, H. K. Ortmeyer, N. L. Bodkin, M. A. Nicolson, and B. C. Hansen Regulation of obese (ob) mRNA and Plasma Leptin Levels in Rhesus Monkeys. EFFECTS OF INSULIN, BODY WEIGHT, AND NON-INSULIN-DEPENDENT DIABETES MELLITUS J. Biol. Chem., October 11, 1996; 271(41): 25327 - 25331. [Abstract] [Full Text] [PDF]

				K. Hotta, T. Funahashi, Y. Matsukawa, M. Takahashi, H. Nishizawa, K. Kishida, M. Matsuda, H. Kuriyama, S. Kihara, T. Nakamura, et al. Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity J. Biol. Chem., August 31, 2001; 276(36): 34089 - 34097. [Abstract] [Full Text] [PDF]

				W. R. Oliver Jr., J. L. Shenk, M. R. Snaith, C. S. Russell, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Winegar, M. L. Sznaidman, M. H. Lambert, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport PNAS, April 24, 2001; 98(9): 5306 - 5311. [Abstract] [Full Text] [PDF]